Single-dose Ketamine Treatment to Improve Depression in Mild Cognitive Impairment
Single-dose Ketamine Treatment to Improve Depression in Mild Cognitive Impairment
Active, not recruiting · NCT06069843 · Registry updated 2025-01-29Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Single-dose Ketamine Treatment to Improve Depression in Mild Cognitive Impairment | Cognition Disorders, Cognitive Dysfunction, Mild Cognitive Impairment, cognitive disorder, depressive disorder, psychiatric disorder | Active, not recruiting | Phase 2 | 2025-01-29 | NCT06069843 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Icahn School of Medicine at Mount Sinai | 256 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Icahn School of Medicine at Mount Sinai (Depression and Anxiety Center) | New York | United States | 1 |